As countries work to make community health workers frontline in their health systems, a new effort is underway to standardize best practices — and ensure that what has been proven to work is put into policy.
Janssen Pharmaceutica and public partners will soon launch a phase 3 trial of the candidate HIV vaccine across three continents. One of the very few HIV candidate vaccines tested on humans to date.
New research by the Center for Global Development unveils major problems with how self-procuring middle-income countries buy and access lifesaving health products. Janeen Madan Keller and Kalipso Chalkidou explain and chart a path forward.
Merck and P&E have signed on as founding members of Women Deliver's Business Ally Network to tackle the barriers to gender equality. Here's what that means.
Here are the biggest takeaways from the 72nd World Health Assembly.
As a private company working in humanitarian health, Aspen Medical continually faces questions on its role in putting the health care needs ahead of its business. But it doesn't shy away from its for-profit model.
The annual event tackles a range of global health issues. Here's what Devex will be keeping a close eye on in Geneva.
The proposal aims to unlock private sector investment for shorter, better tuberculosis treatment regimen.
The Paul G. Allen Family Foundation is calling on government and private funders to support response efforts in the Democratic Republic of the Congo. The foundation previously announced new grants worth $2.4 million, bringing its total commitments to the current crisis to $4 million.
There are four critical barriers to surgery for people living in low- and middle-income countries: capacity, timeliness, safety, and affordability. Two health care professionals from Cameroon share how to overcome them.
Dr. Maria Deloria Knoll celebrates a decade of progress toward ensuring global access to pneumococcal conjugate vaccines in low-income countries.
The global health sector is not being forward-thinking enough about how it views health systems according to the U.N.'s Siddharth Chatterjee. He explains how to overcome "hurdles of the mind" for increased progress in health.
Programs in Kyrgyzstan using new drugs to fight drug-resistant tuberculosis are showing signs of progress, part of USAID's global strategy to build local capacity and work toward a simpler, oral treatment.
Pharma giant GlaxoSmithKline is pursuing a new four-month treatment for tuberculosis but insists it will need support from governments and funding agencies to reach patients in lower-income countries.
WHO director-general and Swedish minister for international development cooperation explore how new partnerships and institutional reforms can fight inequality and advance health outcomes.
In order to achieve significant progress in mental health care, a renewed effort is needed to redefine how it is perceived. Here are four areas where effective communications will help.
Despite the international focus on tuberculosis, there still remains an important challenge — more funding to deliver programs and research to eliminate the disease by 2030.
Germany is funding a research center to coordinate efforts to fight antimicrobial resistance. Here's what it's doing first.